Notably, the survival analyses from the KM plotter revealed lower overall survival time (OS) and post-progression survival (PPS) but not time to first progression (FP) in lung cancer patients with high EIF4A1 expression as well as expression of its correlated genes. The gene discussed is EIF4A1; the disease is lung carcinoma.